In the Boardroom - Merck KGaA

Filter

Current filters:

Merck KGaA

Popular Filters

Merck appoints Wolfgang Büchele as Supervisory Board Chairman

Merck appoints Wolfgang Büchele as Supervisory Board Chairman

12-05-2014

The Supervisory Board of Merck has elected Wolfgang Büchele as Chairman of its corporate governance…

BoardroomGermanyMerck KGaAPharmaceutical

Merck appoints Marcus Kuhnert as Group CFO

Merck appoints Marcus Kuhnert as Group CFO

09-05-2014

Germany’s Merck (MRK: DE) has appointed Marcus Kuhnert as Group Chief Financial Officer. Mr Kuhnert…

BoardroomGermanyMerck KGaAPharmaceuticalUSA

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

26-03-2014

German pharma and chemical major Merck KGaA has announced the promotion of three distinguished internal…

AllergopharmaBiotechnologyBoardroomGermanyMerck KGaAPharmaceutical

Merck names Simon Sturge as new head of biosimilars unit

Merck names Simon Sturge as new head of biosimilars unit

20-02-2014

Germany’s Merck KGaA has appointed Simon Sturge to head the biosimilars unit, effective March 1, succeeding…

BiosimilarsBiotechnologyBoardroomManagementMerck KGaA

Merck KGaA names new board members

Merck KGaA names new board members

28-01-2014

E. Merck KG, which combines the financial interests of the Merck family and is general partner of Germany’s…

BoardroomGermanyMerck KGaAPharmaceutical

Merck KGaA’s CFO Matthias Zachert joins Lanxess as CEO

Merck KGaA’s CFO Matthias Zachert joins Lanxess as CEO

27-01-2014

Chief financial officer of Germany’s Merck KGaA (MRK: DE) Matthias Zachert has been appointed as chief…

BoardroomLanxessMerck KGaAPharmaceutical

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

20-11-2013

German privately-owned biopharmaceutical company Affimed Therapeutics has appointed Jens-Peter Marschner…

Affimed TherapeuticsBoardroomEuropeMerck KGaA

Gerhard Schmitz to join Merck KGaA as new head of global accounting

Gerhard Schmitz to join Merck KGaA as new head of global accounting

30-10-2013

Merck KGaA announced today that Gerhard Schmitz will join the pharmaceutical, chemical and life science…

BoardroomEuropeMerck KGaAPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top